T-cell lymphoma is a highly malignant lymphoma with a poor prognosis. Survival is generally 1-2 years, with a few patients able to survive for more than 5 years. T-cell lymphoma is a common type of malignant lymphoma that is relatively poorly treated and not easily detected. Most patients have stage III or IV tumors by the time they are detected, at which point they do not respond well to chemotherapy or other treatments and have a poor prognosis. If the tumor is detected and treated in the early stage, the prognosis is better. However, each patient’s condition is different and the development of the disease will be different. Correct and timely treatment methods and patients’ positive attitude to cooperate with treatment will promote treatment and prolong the effective survival period, and vice versa will shorten the survival period. No matter what stage the patient is in, he or she should maintain a positive and optimistic attitude, cooperate with the treatment, avoid pessimism and tension, eat a light diet and have regular rest and rest, which will help prolong the survival time and reduce the patient’s pain.